Regenerative Procedures
Autologous Cell Therapies

What is Stem Cell Therapy?

By 2030, knee osteoarthritis is expected to afflict 67 million Americans. Resulting from trauma or age-related degeneration, Osteoarthritis (OA) presents a major clinical challenge due to the limited inherent repair capacity of articular cartilage. Articular cartilage defects are increasingly common among the elderly population and cause pain, reduced joint function, and significant disability.

Despite being a relatively new advancement in regenerative medicine and tissue engineering, autologous cell therapy has the potential to become a new standard in the non-pharmacologic treatment of OA and other common musculoskeletal conditions. Autologous cell therapy supports the self-healing process of the injured tissue, resulting in a relief from symptoms. The autologous cells isolated — mesenchymal autologous cells (MSCs) — have the unique ability to differentiate into other cell types, such as bone, cartilage, muscle and tendon.

Mesenchymal Autologous Cells MSCs

Microscopic Image of MSCs

At RSI, MSCs are harvested directly from the patient’s own blood, bone marrow, or adipose tissue to ensure biocompatibility and minimize donor morbidity. Prior to injection, the cells are carefully separated by centrifugation and undergo a number of other purification processes.

The scientific data supporting the safety and benefits of autologous cell treatments for musculoskeletal disease continues to grow. The shift from surgically removing an injured structure and replacing it with an artificial implant and toward healing the injured structure with an image-guided injection of the patient’s own autologous cells is fully embraced at RSI. RSI is committed to the highest ethical standards regarding autologous cell therapeutics, which stipulate only providing safe therapies that are of proven scientific benefit. These standards require conducting intensive outcomes tracking and reporting through our clinical research registry.

Conditions Treated by Autologous Cells

Autologous Conditions

At RSI we use autologous cells to treat the following conditions:
  • Lumbar disc disease
  • Osteoarthritis of the knee, shoulder and hip
  • Meniscal / labral tears
  • Tendonitis
  • Partial tendon tears
  • Ligament sprains or tears
  • Plantar fasciitis
RSI IS PROUD TO BE AFFILIATED WITH: